Presenting author
Samuel Wilkinson
3 presentations
Conducting clinical trials using combined treatment modalities: Challenges, opportunities, and insights for future regulatory consideration
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE study
Ketamine for depression, but at what cost? Evidence for neurotoxicity from human and animal studies